FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/14/2023
Back to search
Official data from USPTO
PIONEER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PIONEER
ST13
US500000079329052Class
1, 5, 40, 42
Filing
79329052
Registration
7021191
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/14/2023
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
10/06/2021
Registration date
04/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
04/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
MALYSZEK, KIMBERLY
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bio-Rad Europe GmbH
Bio-Rad Laboratories GmbH
Representatives
Margaret C. McHugh Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and sciencediagnostic kits consisting primarily of antibodies and reagents for use in disease testing; biological preparations in the nature of antibodies for research useother than for medical or veterinary purposes; antibody librariesfor scientificindustrial or research usebiological preparations in the nature of antibodies sold together; libraries of immunoglobulinsantibodiesfragments thereoffor scientificindustrialresearch usebiological preparations in the nature of immunoglobulinsantibodiesfragments thereof sold together as a kit; biological preparations in the nature of immunoglobulinsantibodiesfragments thereoffor scientificindustrialresearch use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagentsboth for scientific or research use in the field of diagnosing diseases
Class 5
Biological preparations for the treatment of infectious diseasesdeficiency diseaseshereditary diseasesphysiological diseases; pharmaceuticalbiopharmaceutical and medical preparations for the treatment of infectious diseasesdeficiency diseaseshereditary diseasesphysiological diseases; diagnostic preparations for medical purposes; antibodies for medical purposes; biological preparationsimmunoglobulinsantibodiesfragments thereoffor medical use; antibody librariesfor medical and veterinary usecollections of antibodies for medical purposes; libraries of immunoglobulinsantibodiesfragments thereoffor medical usecollections of biological preparations in the nature of immunoglobulinsantibodiesfragments thereoffor medical usesold as a unit; biological preparations comprised of immunoglobulinsantibodiesfragments thereoffor use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical clinician or medical use
Class 40
Antibody production for othersmanufacture of antibodies for others; custom manufacture of antibodiesantibody purificationantibody fragmentation; custom production of cell cultures and biological products in the nature of antibodies and proteins and related reagents; custom antibody production; custom manufacturing for othersmanufacturing of chemical and biotechnological materials for othersmanufacturing of organismscompounds and materials for use in the pharmaceuticalagrochemicalchemicalbiotechnology industries
Class 42
Research and development in the field of antibody generation services; medical and scientific research for the identificationpreparationdevelopment of antibody libraries; Chemicalbiochemicalbiological and bacteriological research and analysis services in the nature of preparation and screening of libraries of proteins and antibodieslibraries of cells producing antibodies and proteinslibraries of vector coding for antibodies and proteins; design of antibody libraries for medical or veterinary use; scientific and technological servicesscientific and technological researchanalysisinspectionquality auditconsultingdesignengineeringdevelopment and laboratory testing services for others; research and development services in the field of developing new chemicals; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; providing information and consultancy on testinginspection or research of pharmaceuticalschemicals for use in medicinesreagents for use in medicinescosmetics or foodstuffs; scientific or laboratory testinginspection or research of nucleic acidschemicals and pharmaceuticals for drug development and medical research purposesproviding scientific information and research consultancy relating thereto; genomic experimentsanalysesresearchassaystestsinspectiondetection or verificationscientific laboratory services being scientific genomic analysesscientific genomic researchcustom design and development of biochemical genomic assaysgenome amplification and functional and structural analysis of genomes; scientific laboratory services of a chemistbiologistbiochemistbiotechnologistsgene technologistsmolecular biologistspharmacistsprotein chemist; chemical and biological analysis and research services; pharmaceuticalmedicalscientific and biopharmaceutical research and development; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/26/2023
FIMP
FINAL DISPOSITION PROCESSED
07/26/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/24/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/20/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/20/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2022
RFNT
REFUSAL PROCESSED BY IB
07/19/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/25/2022
RFRR
REFUSAL PROCESSED BY MPU
06/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/17/2022
CNRT
NON-FINAL ACTION WRITTEN
06/16/2022
DOCK
ASSIGNED TO EXAMINER
06/15/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/23/2021
Continuous trademark protection
Get notified about every new filing that threatens PIONEER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.